Pricing Log in Create free account

BGM Group Ltd. (BGM) vs Cardiol Therapeutics Inc. (CRDL)

BGM Group Ltd. and Cardiol Therapeutics Inc. are both Drug Manufacturers Specialty & Generic companies. BGM Group Ltd. is the larger, with a market value of $125.7M against $111.8M — 1.1× the size. Cardiol Therapeutics Inc. has negative trailing earnings, so its P/E is not meaningful; BGM Group Ltd. trades at 148×. BGM Group Ltd. has the higher net margin (1.96% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 9 metrics below, BGM Group Ltd. leads on 6 and Cardiol Therapeutics Inc. on 3.

Valuation

Metric BGM CRDL Drug Manufacturers Specialty & Generic median
P/E 148.17 n/m 20.55
P/S n/m n/m 2.08
P/B n/m 6.16 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales (0.09) n/m 2.87
Earnings yield 0.67% (26.88%) (15.94%)
Free cash flow yield 0.00% (16.13%) 0.00%

Profitability

Metric BGM CRDL Drug Manufacturers Specialty & Generic median
Gross margin 6.54% 0.00% 53.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 1.96% 0.00% (2.45%)
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (171.13%) (0.80%)
Return on assets 0.00% (124.40%) (1.67%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BGM CRDL Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — — 5.22%
EPS growth (last fiscal year) 10.00% 24.32% 42.91%
Revenue growth, 5-year CAGR (5.39%) — 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BGM CRDL Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.00 0.04
Current ratio 1.25 5.55 2.41
Net debt to EBITDA 0.97 0.62 1.01

Dividend

Metric BGM CRDL Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric BGM CRDL Drug Manufacturers Specialty & Generic median
Market cap 125.72m 111.79m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack